Allergic Rhinitis Control Test (ARCT) has been validated for assessing allergic rhinitis (AR) control and to identify severe AR. The aim of the study was to assess the ARCT questionnaire as a tool for stepwise pharmacotherapy.
A standard pharmacotherapy regimen from step 1 (oral second generation H1 antihistamine as needed) to step 5 (oral corticosteroid) was carried out prospectively in a Chinese AR population. The AR patients were initiated with Allergic Rhinitis and its Impact on Asthma (ARIA) appropriate step treatment and assessed with ARCT every 15 days. If ARCT score was equal or above 20 (controlled AR) and maintained for 15 days, the patient would finish the study; if ARCT score was strictly less than 20 (uncontrolled AR), the patient would receive higher step treatment according to a predefined open design up to step 5. The different AR control subgroups were compared.
255 patients were enrolled in the study; 5 patients dropped out. 2(0.8%) were controlled at day 0, 85(34.0%) at day 15, 177(70.8%) at day 30, 222(88.8%) at day 45, 241(96.4%) at day 60 and 242(96.8%) at day 75. Only 8(3.2%) patients remained uncontrolled at the endpoint of the study. Patients with ARIA moderate/severe or persistent symptoms, moderate/severe impaired quality of life, asthma history, rhinorrhea and cough symptoms always needed up to step 4 (nasal corticosteroid plus antihistamine) and prolonged treatments to achieve disease control.
The majority of AR can be controlled with standard stepwise treatment. ARCT offers an objective criterion for the stepwise pharmacotherapy of AR. This article is protected by copyright. All rights reserved.
Pharmacology, Toxicology and Pharmaceutical Science
2
7%
Arts and Humanities
1
3%
Biochemistry, Genetics and Molecular Biology
1
3%
Agricultural and Biological Sciences
1
3%
Other
1
3%
Unknown
15
50%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2024.
All research outputs
#3,973,461
of 33,087,078 outputs
Outputs from Allergy
#1,883
of 7,427 outputs
Outputs of similar age
#47,737
of 329,631 outputs
Outputs of similar age from Allergy
#24
of 62 outputs
Altmetric has tracked 33,087,078 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,427 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.8. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,631 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
